Physician profile
Patrick Mckenzie
NPI 1225359920
$2,922.89
in general payments reported to CMS, 2019-2025
25 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $144 · 2021: $253 · 2022: $723 · 2023: $362 · 2024: $488 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $654.04 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $480.98 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $377.02 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $217.25 | 2019-2024 | Xiaflex, Aveed |
| Teleflex LLC | $145.94 | 2021-2025 | Urolift |
| Myovant Sciences INC. | $140.55 | 2021-2022 | |
| Urovant Sciences INC | $125.36 | 2021-2022 | |
| Pfizer INC. | $116.30 | 2021-2025 | |
| Boston Scientific Corporation | $79.10 | 2019-2025 | Axonics |
| Merck Sharp & Dohme LLC | $76.87 | 2024 | Keytruda, Welireg |
| Medtronic, INC. | $66.90 | 2023-2025 | Interstim, Altaviva |
| Bayer Healthcare Pharmaceuticals INC. | $64.24 | 2019-2020 | |
| Abbvie INC. | $58.67 | 2022-2024 | |
| Amgen INC. | $46.57 | 2019-2020 | |
| Tolmar, INC. | $45.41 | 2023-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $43.86 | 2020-2022 | |
| Photocure INC | $31.48 | 2025 | Cysview |
| Urogen Pharma, INC. | $28.82 | 2025 | |
| Novartis Pharmaceuticals Corporation | $26.94 | 2025 | |
| Telix Pharmaceuticals | $20.71 | 2025 | Illuccix |
| Laborie Medical Technologies Corp. | $17.68 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ethicon US, LLC | $15.56 | 2024 | Stratafix |
| Endo USA, INC. | $14.78 | 2025 | Xiaflex, Aveed |
| Cycle Pharmaceuticals INC | $14.37 | 2025 | Venxxiva |
| Allergan, INC. | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.